Current Status of Liver Transplantation Using Marginal Grafts

References

• Sakamoto S, Sasaki K, Uchida H. A severely cholestatic liver graft can be successfully used in deceased donor liver transplantation. Hepatol Res. 2018;48(3):E367–E371.
   PubMed Web of Science ®Google Scholar
• Attia M, Silva MA, Mirza DF. The marginal liver donor-an update. Transpl Int. 2008;21(8):713–724.
   PubMed Web of Science ®Google Scholar
• Umeshita K, Inomata Y, Furukawa H, et al. Liver transplantation in Japan: registry by the Japanese Liver Transplantation Society. Hepatol Res. 2016;46(12):1171–1186.
   PubMed Web of Science ®Google Scholar
• Tanemura A, Mizuno S, Wada H, Yamada T, Nobori T, Isaji S. Donor age affects liver regeneration during early period in the graft liver and late period in the remnant liver after living donor liver transplantation. World J Surg. 2012;36(5):1102–1111.
   PubMed Web of Science ®Google Scholar
• Han JH, You YK, Na GH, et al. Outcomes of living donor liver transplantation using elderly donors. Ann Surg Treat Res. 2014;86(4):184–191.
   PubMed Web of Science ®Google Scholar
• Serste T, Bourgeois N. Ageing and the liver. Acta Gastroenterol Belg. 2006;69(3):296–298.
   PubMed Web of Science ®Google Scholar
• Ghinolfi D, Lai Q, Pezzati D, De Simone P, Rreka E, Filipponi F. Use of elderly donors in liver transplantation: a paired-match analysis at a single center. Ann Surg 2018;268(2):325–331.
   PubMed Web of Science ®Google Scholar
• Kamo N, Kaido T, Hammad A, et al. Impact of elderly donors for liver transplantation: A single‐center experience. Liver Transpl. 2015;21(5):591–598.
   PubMed Web of Science ®Google Scholar
• Dasari BVM, Schlegel A, Mergental H, Perera MTPR. The use of old donors in liver transplantation. Best Pract Res Clin Gastroenterol. 2017;31(2):211–217.
   PubMed Web of Science ®Google Scholar
• Jiménez-Romero C, Maestro OC, Molero FC, et al. Using old liver grafts for liver transplantation: where are the limits? World J Gastroenterol. 2014;20(31):10691–10702.
   PubMed Web of Science ®Google Scholar
• Kim DY, Moon J, Island ER, et al. Liver transplantation using elderly donors: a risk factor analysis. Clin Transplant. 2011;25(2):270–276.
   PubMed Web of Science ®Google Scholar
• Campos PAC, Romero PR, Gonzalez R, et al. Improving the waiting list by using 75-year-old donors for recipients with hepatocellular carcinoma. Transplant Proc. 2010;42(2):627–630.
   PubMed Web of Science ®Google Scholar
• Westerkamp AC, Korkmaz KS, Bottema JT, et al. Elderly donor liver grafts are not associated with a higher incidence of biliary complications after liver transplantation: results of a national multicenter study. Clin Transplant. 2015;29(7):636–643.
   PubMed Web of Science ®Google Scholar
• Dasari BV, Mergental H, Isaac JR, Muiesan P, Mirza DF, Perera MTP. Systematic review and meta-analysis of liver transplantation using grafts from deceased donors aged over 70-years. Clin Transplant. 2017;31(12):e13139.
   PubMed Web of Science ®Google Scholar
• Selzner M, Kashfi A, Selzner N, et al. Recipient age affects long‐term outcome and hepatitis C recurrence in old donor livers following transplantation. Liver Transpl. 2009;15(10):1288–1295.
   PubMed Web of Science ®Google Scholar
• Durand F, Renz JF, Alkofer B, et al. Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transpl. 2008;14(12):1694–1707.
   PubMed Web of Science ®Google Scholar
• Halldorson JB, Bakthavatsalam R, Fix O, Reyes JD, Perkins JD. D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching. Am J Transplant. 2009;9(2):318–326.
   PubMed Web of Science ®Google Scholar
• Avolio AW, Cillo U, Salizzoni M, et al. Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients . Am J Transplant. 2011;11(12):2724–2736.
   PubMed Web of Science ®Google Scholar
• Cepeda-Franco C, Bernal-Bellido C, Barrera-Pulido L, et al. Survival outcomes in liver transplantation with elderly donors: analysis of andalusian transplant register. Transplant Proc. 2016;48(9):2983–2986.
   PubMed Web of Science ®Google Scholar
• Han JH, Kim DG, Na GH, et al. Effect of donor–recipient age matching in living donor liver transplantation. Transplant Proc. 2015;47(3):718–722.
   PubMed Web of Science ®Google Scholar
• Hidaka M, Eguchi S, Takatsuki M, et al. The Kupffer cell number affects the outcome of living donor liver transplantation from elderly donors. Transplant Direct. 2016;2(8):e94.
   PubMed Web of Science ®Google Scholar
• Yoshizumi T, Taketomi A, Soejima Y, et al. Impact of donor age and recipient status on left‐lobe graft for living donor adult liver transplantation. Transplant Int. 2008;21:81–88.
   Web of Science ®Google Scholar
• Dayangac M, Taner CB, Yaprak O, et al. Utilization of elderly donors in living donor liver transplantation: when more is less? Liver Transpl. 2011;17(5):548–555.
   PubMed Web of Science ®Google Scholar
• Kubota T, Hata K, Sozu T, et al. Impact of donor age on recipient survival in adult-to-adult living-donor liver transplantation. Ann Surg 2017; 267(6):1126–1133.
   Web of Science ®Google Scholar
• Abdel-Wahab M, Abdel-Khalek EE, El-Gilany AH, et al. Predictors of hepatitis C virus recurrence after living donor liver transplantation: Mansoura experience. Arab J Gastroenterol. 2017;18(3):151–155.
   PubMed Web of Science ®Google Scholar
• Chu MJJ, Dare AJ, Phillips ARJ, Bartlett ASJR. Donor hepatic steatosis and outcome after liver transplantation: a systematic review. J Gastrointest Surg. 2015;19(9):1713–1724.
   PubMed Web of Science ®Google Scholar
• de Graaf EL, Kench J, Dilworth P, et al. Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the donor risk index. J Gastroenterol Hepatol. 2012;27(3):540–546.
   PubMed Web of Science ®Google Scholar
• Wong TCL, Fung JYY, Chok KSH, et al. Excellent outcomes of liver transplantation using severely steatotic grafts from brain‐dead donors. Liver Transpl. 2016;22(2):226–236.
   PubMed Web of Science ®Google Scholar
• Mokuno Y, Berthiaume F, Tompkins RG, Balis UJ, Yarmush ML. Technique for expanding the donor liver pool: heat shock preconditioning in a rat fatty liver model. Liver Transpl. 2004;10(2):264–272.
   PubMed Web of Science ®Google Scholar
• Nagrath D, Xu H, Tanimura Y, et al. Metabolic preconditioning of donor organs: defatting fatty livers by normothermic perfusion ex vivo. Metab Eng. 2009;11(4–5):274–283.
   PubMed Web of Science ®Google Scholar
• Kron P, Schlegel A, Mancina L, Clavien P-A, Dutkowski P. Hypothermic oxygenated perfusion (HOPE) for fatty liver grafts in rats and humans. J Hepatol. 2017;S0168–8278(17):32268–32267.
   Google Scholar
• McCormack L, Petrowsky H, Jochum W, Furrer K, Clavien P-A. Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study. Ann Surg. 2007;245(6):923–930.
   PubMed Web of Science ®Google Scholar
• d'Assignies G, Fayard C, Leitao H, et al. Liver steatosis assessed by preoperative MRI: an independent risk factor for severe complications after major hepatic resection. Surgery. 2016;159(4):1050–1057.
   PubMed Web of Science ®Google Scholar
• Han S, Ko JS, Kwon G, et al. Effect of pure microsteatosis on transplant outcomes after living donor liver transplantation: a matched case‐control study. Liver Transpl. 2014;20(4):473–482.
   PubMed Web of Science ®Google Scholar
• Cho JY, Suh KS, Kwon CH, et al. The hepatic regeneration power of mild steatotic grafts is not impaired in living-donor liver transplantation. Liver Transpl. 2005;11(2):210–217.
   PubMed Web of Science ®Google Scholar
• Marcos A, Fisher RA, Ham JM, et al. Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplantation 2000;69(7):1375–1379.
   PubMed Web of Science ®Google Scholar
• Soejima Y, Shimada M, Suehiro T, et al. Use of steatotic graft in living-donor liver transplantation. Transplantation 2003;76(2):344–348.
   PubMed Web of Science ®Google Scholar
• Hayashi M, Fujii K, Kiuchi T, et al. Effects of fatty infiltration of the graft on the outcome of living-related liver transplantation. Transpl Proc. 1999;31(1–2):403.
   PubMed Web of Science ®Google Scholar
• Nakamuta M, Morizono S, Soejima Y, et al. Short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation. Transplantation 2005;80(5):608–612.
   PubMed Web of Science ®Google Scholar
• Doyle A, Adeyi O, Khalili K, et al. Treatment with Optifast reduces hepatic steatosis and increases candidacy rates for living donor liver transplantation. Liver Transpl. 2016;22(9):1295–1300.
   PubMed Web of Science ®Google Scholar
• Oshita A, Tashiro H, Amano H, et al. Safety and feasibility of diet-treated donors with steatotic livers at the initial consultation for living-donor liver transplantation. Transplantation 2012;93(10):1024–1030.
   PubMed Web of Science ®Google Scholar
• Marsman HA, Heger M, Kloek JJ, Nienhuis SL, ten Kate FJW, Van Gulik TM. Omega-3 fatty acids reduce hepatic steatosis and consequently attenuate ischemia-reperfusion injury following partial hepatectomy in rats. Dig Liver Dis. 2011;43(12):984–990.
   PubMedGoogle Scholar
• Loggi E, Conti F, Cucchetti A, Ercolani G, Pinna AD, Andreone P. Liver grafts from hepatitis B surface antigen-positive donors: a review of the literature. World J Gastroenterol. 2016;22(35):8010–8016.
   PubMed Web of Science ®Google Scholar
• Martini S, David E, Tandoi F, et al. HCV viremic donors with hepatic bridging fibrosis: are we ready to use their livers in the era of direct‐acting antivirals? Am J Transplant. 2017;17(11):2986–2987.
   PubMed Web of Science ®Google Scholar
• Cholongitas E, Papatheodoridis GV, Burroughs AK. Liver grafts from anti-hepatitis B core positive donors: a systematic review. J Hepatol. 2010;52(2):272–279.
   PubMed Web of Science ®Google Scholar
• Skagen CL, Jou JH, Said A. Risk of de novo hepatitis in liver recipients from hepatitis‐B core antibody‐positive grafts–a systematic analysis. Clin Transplant. 2011;25(3):E243–E1172.
   PubMed Web of Science ®Google Scholar
• Huprikar S, Danziger-Isakov L, Ahn J, et al. Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management. Am J Transplant. 2015;15(5):1162–1172.
   PubMed Web of Science ®Google Scholar
• Krishnamoorthi R, Manickam P, Cappell MS. Liver transplantation of hepatitis B surface antigen positive donors to hepatitis B core antibody recipients: analysis of 27 patients. Minerva Gastroenterol Dietol. 2014;60(2):113–118.
   PubMedGoogle Scholar
• Ballarin R, Cucchetti A, Russo FP, et al. Long-term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors. World J Gastroenterol. 2017;23(12):2095–2105.
   PubMed Web of Science ®Google Scholar
• Levitsky J, Formica RN, Bloom RD, et al. The American Society of transplantation consensus conference on the use of hepatitis C viremic donors in solid organ transplantation. Am J Transplant. 2017;17(11):2790–2802.
   PubMed Web of Science ®Google Scholar
• Stepanova M, Sayiner M, de Avila L, Younoszai Z, Racila A, Younossi ZM. Long-term outcomes of liver transplantation in patients with hepatitis C infection are not affected by HCV positivity of a donor. BMC Gastroenterol. 2016;16(1):137.
   PubMed Web of Science ®Google Scholar
• Torosian JC, Leiby BE, Fenkel JM, Frank AM, Ramirez CG, Doria C. Liver retransplantation for recurrence of HCV-related cirrhosis using Hepatitis C-positive allografts: a 19-Year OPTN analysis. Ann Transplant. 2016;21:262–269.
   PubMed Web of Science ®Google Scholar
• Uemura T, Wada S, Kaido T, et al. How far can we lower graft-to-recipient weight ratio for living donor liver transplantation under modulation of portal venous pressure? Surgery. 2016;159(6):1623–1630.
   PubMed Web of Science ®Google Scholar
• Wang S-H, Loh P-Y, Lin T-L, et al. Active immunization for prevention of De novo hepatitis B virus infection after adult living donor liver transplantation with a hepatitis B core antigen-positive graft. Liver Transpl. 2017;23(10):1266–1272.
   PubMed Web of Science ®Google Scholar
• Lo CM, Fan ST, Liu CL, et al. Safety and outcome of hepatitis B core antibody-positive donors in right-lobe living donor liver transplantation. Liver Transplant. 2003;9(8):827–832.
   PubMed Web of Science ®Google Scholar
• Takeichi T, Asonuma K, Yamamoto H, et al. Liver transplant from an ABO-incompatible and hepatitis C antibody-positive but an HCV-RNA negative living donor in a familial amyloid polyneuropathy patient. Exp Clin Transplant. 2013;11(2):182–185.
   PubMed Web of Science ®Google Scholar
• Johnson RJ, Bradbury LL, Martin K, Neuberger J. Organ donation and transplantation in the UK—the last decade: a report from the UK national transplant registry. Transplantation 2014;97:S1–S27.
   PubMed Web of Science ®Google Scholar
• Kim WR, Lake JR, Smith JM, et al. OPTN/SRTR 2015 Annual data report: liver. Am J Transplant. 2017;17:174–251.
   PubMed Web of Science ®Google Scholar
• Thuong M, Ruiz A, Evrard P, et al. New classification of donation after circulatory death donors definitions and terminology. Transpl Int. 2016;29(7):749–759.
   PubMed Web of Science ®Google Scholar
• Hashimoto K, Miller C. The use of marginal grafts in liver transplantation. J Hepatobiliary Pancreat Surg. 2008;15(2):92–101.
   PubMedGoogle Scholar
• Suárez F, Otero A, Solla M, et al. Biliary complications after liver transplantation from Maastricht Category-2 non-heart-beating donors. Transplantation. 2008;85(1):9–14.
   PubMed Web of Science ®Google Scholar
• Otero A, Gómez-Gutiérrez M, Suárez F, et al. Liver transplantation from Maastricht category 2 non-heart-beating donors. Transplantation. 2003;76(7):1068–1073.
   PubMed Web of Science ®Google Scholar
• Casavilla A, Ramirez C, Shapiro R, et al. Experience with liver and kidney allografts from non-heart-beating donors. Transplantation 1995;59(2):197–203.
   PubMed Web of Science ®Google Scholar
• Blok JJ, Detry O, Putter H, et al. Longterm results of liver transplantation from donation after circulatory death. Liver Transpl. 2016;22(8):1107–1114.
   PubMed Web of Science ®Google Scholar
• O'Neill S, Roebuck A, Khoo E, Wigmore SJ, Harrison EM. A meta-analysis and meta-regression of outcomes including biliary complications in donation after cardiac death liver transplantation. Transpl Int. 2014;27(11):1159–1174.
   PubMed Web of Science ®Google Scholar
• Croome KP, Lee DD, Perry DK, et al. Comparison of long-term outcomes and quality of life in recipients of donation after cardiac death liver grafts with a propensity‐matched cohort. Liver Transpl. 2017;23(3):342–351.
   PubMed Web of Science ®Google Scholar
• Mateo R, Cho Y, Singh G, et al. Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN/UNOS data. Am J Transplant. 2006;6(4):791–796.
   PubMed Web of Science ®Google Scholar
• Hashimoto K, Eghtesad B, Gunasekaran G, et al. Use of tissue plasminogen activator in liver transplantation from donation after cardiac death donors. Am J Transplant. 2010;10(12):2665–2672.
   PubMed Web of Science ®Google Scholar
• Jay C, Ladner D, Wang E, et al. A comprehensive risk assessment of mortality following donation after cardiac death liver transplant–an analysis of the national registry. J Hepatol. 2011;55(4):808–813.
   PubMed Web of Science ®Google Scholar
• Foley DP, Fernandez LA, Leverson G, et al. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center. Ann Surg. 2011;253(4):817–825.
   PubMed Web of Science ®Google Scholar
• De Vera ME, Lopez-Solis R, Dvorchik I, et al. Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center. Am J Transplant. 2009;9(4):773–781.
   PubMed Web of Science ®Google Scholar
• Pine JK, Aldouri A, Young AL, et al. Liver transplantation following donation after cardiac death: an analysis using matched pairs. Liver Transpl. 2009;15(9):1072–1082.
   PubMed Web of Science ®Google Scholar
• Mathur AK, Heimbach J, Steffick DE, Sonnenday CJ, Goodrich NP, Merion RM. Donation after cardiac death liver transplantation: predictors of outcome. Am J Transplant. 2010;10(11):2512–2519.
   PubMed Web of Science ®Google Scholar
• Reich DJ, Hong JC. Current status of donation after cardiac death liver transplantation. Curr Opin Organ Transplant. 2010;15(3):316–321.
   PubMed Web of Science ®Google Scholar
• Taner CB, Bulatao IG, Perry DK, et al. Asystole to cross‐clamp period predicts development of biliary complications in liver transplantation using donation after cardiac death donors. Transpl Int. 2012;25(8):838–846.
   PubMed Web of Science ®Google Scholar
• Seal JB, Bohorquez H, Reichman T, et al. Thrombolytic protocol minimizes ischemic‐type biliary complications in liver transplantation from donation after circulatory death donors. Liver Transpl. 2015;21(3):321–328.
   PubMed Web of Science ®Google Scholar
• Dutkowski P, Polak WG, Muiesan P, et al. First comparison of hypothermic oxygenated PErfusion versus static cold storage of human donation after cardiac death liver transplants. Ann Surg. 2015;262(5):764–771.
   PubMed Web of Science ®Google Scholar
• De Carlis R, Di Sandro S, Lauterio A, et al. Successful donation after cardiac death liver transplants with prolonged warm ischemia time using normothermic regional perfusion. Liver Transpl. 2017;23(2):166–173.
   PubMed Web of Science ®Google Scholar
• Brüggenwirth IMA, Dolgin NH, Porte RJ, Bozorgzadeh A, Martins PNA. Donor diabetes and prolonged cold ischemia time synergistically increase the risk of graft failure after liver transplantation. Transplant Direct. 2017;3(7):e173.
   PubMed Web of Science ®Google Scholar
• Pan ET, Yoeli D, Galvan NTN, et al. Cold ischemia time is an important risk factor for post‐liver transplant prolonged length of stay. Liver Transplant. 2018;24(6):762–768.
   PubMed Web of Science ®Google Scholar
• Grąt M, Wronka KM, Patkowski W, et al. Effects of donor age and cold ischemia on liver transplantation outcomes according to the severity of recipient status. Dig Dis Sci. 2016;61(2):626–635.
   PubMed Web of Science ®Google Scholar
• Sibulesky L, Li M, Hansen RN, et al. Impact of cold ischemia time on outcomes of liver transplantation: a single center experience. Ann Transplant. 2016;21:145–151.
   PubMed Web of Science ®Google Scholar
• Segev DL, Kucirka LM, Nguyen GC, et al. Effect modification in liver allografts with prolonged cold ischemic time. Am J Transplant. 2008;8(3):658–666.
   PubMed Web of Science ®Google Scholar
• Stahl JE, Kreke JE, Malek FAA, Schaefer AJ, Vacanti J. Consequences of cold-ischemia time on primary nonfunction and patient and graft survival in liver transplantation: a meta-analysis. PLoS One. 2008;3(6):e2468.
   PubMed Web of Science ®Google Scholar
• Graham JA, Guarrera JV. Resuscitation of marginal liver allografts for transplantation with machine perfusion technology. J Hepatol. 2014;61(2):418–431.
   PubMed Web of Science ®Google Scholar
• Dutkowski P, De Rougemont O, Clavien P. Machine perfusion for 'marginal' liver grafts. Am J Transplant. 2008;8(5):917–924.
   PubMed Web of Science ®Google Scholar
• Ravikumar R, Jassem W, Mergental H, et al. Liver transplantation after ex vivo normothermic machine preservation: a phase 1 (First‐in‐Man) clinical trial. Am J Transplant. 2016;16(6):1779–1787.
   PubMed Web of Science ®Google Scholar
• Nasralla D, Coussios CC, Mergental H, et al. A randomized trial of normothermic preservation in liver transplantation. Nature. 2018;557(7703):50–56.
   Google Scholar
• Hashimoto K, Quintini C, Aucejo FN, et al. Split liver transplantation using hemiliver graft in the MELD era: a single center experience in the United States. Am J Transplant. 2014;14(9):2072–2080.
   PubMed Web of Science ®Google Scholar
• Vagefi PA, Parekh J, Ascher NL, Roberts JP, Freise CE. Outcomes with split liver transplantation in 106 recipients: the University of California, San Francisco, experience from 1993 to 2010. Arch Surg. 2011;146(9):1052–1059.
   PubMedGoogle Scholar
• Broelsch CE, Emond JC, Whitington PF, Thistlethwaite JR, Baker AL, Lichtor JL. Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg. 1990;212(3):368–375.
   PubMed Web of Science ®Google Scholar
• Emond JC, Whitington PF, Thistlethwaite JR, et al. Transplantation of two patients with one liver. Analysis of a preliminary experience with ‘split-liver’ grafting. Ann Surg. 1990;212(1):14–22.
   PubMed Web of Science ®Google Scholar
• Hong JC, Yersiz H, Busuttil RW. Where are we today in split liver transplantation? Curr Opin Organ Transplant. 2011;16(3):269–273.
   PubMed Web of Science ®Google Scholar
• Merion RM, Rush SH, Dykstra DM, Goodrich N, Freeman RB, Wolfe RA. Predicted lifetimes for adult and pediatric split liver versus adult whole liver transplant recipients. Am J Transplant. 2004;4(11):1792–1797.
   PubMed Web of Science ®Google Scholar
• Nesher E, Island E, Tryphonopoulos P, et al. Split liver transplantation. Transplant Proc. 2011;43(5):1736–1741.
   Google Scholar
• Hong JC, Yersiz H, Farmer DG, et al. Long-term outcomes for whole and segmental liver grafts in adult and pediatric liver transplant recipients: a 10-year comparative analysis of 2,988 cases. J Am Coll Surg. 2009;208(5):682–689.
   PubMed Web of Science ®Google Scholar
• Gridelli B, Spada M, Petz W, et al. Split-liver transplantation eliminates the need for living-donor liver transplantation in children with end-stage cholestatic liver disease. Transplantation. 2003;75(8):1197–1203.
   PubMed Web of Science ®Google Scholar
• Cardillo M, De Fazio N, Pedotti P, et al. Split and whole liver transplantation outcomes: a comparative cohort study. Liver Transplant 2006;12(3):402–410.
   PubMed Web of Science ®Google Scholar
• Sampietro R, Goffette P, Danse E, et al. Extension of the adult hepatic allograft pool using split liver transplantation. Acta Gastroenterol Belg. 2005;68(3):369–375.
   PubMed Web of Science ®Google Scholar
• Greif F, Bronsther OL, Van Thiel DH, et al. The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg. 1994;219(1):40–45.
   PubMed Web of Science ®Google Scholar
• Doyle MBM, Maynard E, Lin Y, et al. Outcomes with split liver transplantation are equivalent to those with whole organ transplantation. J Am Coll Surg. 2013;217(1):102–112.
   PubMed Web of Science ®Google Scholar
• Battula NR, Platto M, Anbarasan R, et al. Intention to split policy: a successful strategy in a combined pediatric and adult liver transplant center. Ann Surg. 2017;265(5):1009–1015.
   PubMed Web of Science ®Google Scholar
• Wan P, Li Q, Zhang J, Xia Q. Right lobe split liver transplantation versus whole liver transplantation in adult recipients: a systematic review and meta‐analysis. Liver Transpl. 2015;21(7):928–943.
   PubMed Web of Science ®Google Scholar
• Angelico R, Nardi A, Adam R, et al. Outcomes of left split graft transplantation in Europe: Report from the European Liver Transplant Registry. Transpl Int. 2018;31 (7):739–750.
   PubMed Web of Science ®Google Scholar
• Dageforde LA, Chapman W. Split liver grafts can benefit both pediatric and adult liver transplant recipients and programs. Pediatr Transpl. 2017;21(4):e12934. doi:10.1111/petr.12934
   Web of Science ®Google Scholar
• Cheah YL, Simpson MA, Pomposelli JJ, Pomfret EA. Incidence of death and potentially life‐threatening near‐miss events in living donor hepatic lobectomy: a world‐wide survey. Liver Transpl. 2013;19(5):499–506.
   PubMed Web of Science ®Google Scholar
• Roll GR, Parekh JR, Parker WF, et al. Left hepatectomy versus right hepatectomy for living donor liver transplantation: shifting the risk from the donor to the recipient. Liver Transpl. 2013;19(5):472–481.
   PubMed Web of Science ®Google Scholar
• Chen CL, Kabiling CS, Concejero AM. Why does living donor liver transplantation flourish in Asia? Nat Rev Gastroenterol Hepatol. 2013;10(12):746–751.
   PubMed Web of Science ®Google Scholar
• Bell R, Pandanaboyana S, Nisar S, Gurusamy K, Prasad R. Systematic review and meta-analysis of graft recipient weight ratio and impact on small for size syndrome, perioperative outcomes and survival in living donor liver transplantation. HPB 2016;18:e574.
   Google Scholar
• Ito T, Kiuchi T, Yamamoto H, et al. Changes in portal venous pressure in the early phase after living donor liver transplantation: pathogenesis and clinical implications. Transplantation 2003;75(8):1313–1317.
   PubMed Web of Science ®Google Scholar
• Man K, Lo CM, Ng IO, et al. Liver transplantation in rats using small-for-size grafts: a study of hemodynamic and morphological changes. Arch Surg. 2001;136(3):280–285.
   PubMedGoogle Scholar
• Kaido T, Mori A, Ogura Y, et al. Lower limit of the graft-to-recipient weight ratio can be safely reduced to 0.6% in adult-to-adult living donor liver transplantation in combination with portal pressure control. Transplant Proc. 2011;43(6):2391–2393.
   PubMed Web of Science ®Google Scholar
• Ikegami T, Yoshizumi T, Sakata K, et al. Left lobe living donor liver transplantation in adults: What is the safety limit? Liver Transpl. 2016;22(12):1666–1675.
   PubMed Web of Science ®Google Scholar